Posted: 14 December 2023 With the execution of a new Memorandum of Understanding (MoU), MTPConnect and the Korea Health Industry Development Institute (KHIDI) have committed to working closely together to support the growth of health and medical technology,…
Posted: 14 December 2023 Patrys is pleased to announce that its Contract Manufacturing and Development Oganisation (CDMO) has confirmed that a manufacturing slot for the GMP (Good Manufacturing Practice) production of PAT-DX1 will be available in Q1 CY…
Posted: 12 December 2023 Health Security Systems Australia (HSSA), a division of Australian public company DMTC Limited, has announced plans for the transiton of the division’s leadership. Dr Leigh Farrell, who has been involved with DMTC since 2015…
Posted: 12 December 2023 Critical investment is accelerating the commercialisation of world-first Victorian technology to treat brain injuries, creating jobs at home and potentially benefiting patients around the globe. Minister for Economic Growth Tim Pallas today announced a…
Posted: 12 December 2023 Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) today announces that it has signed a binding agreement (Merger Agreement) for the acquisition of Imbio (Acquisition), a U.S.-based medical technology company that…
Posted: 12 December 2023 Imagion Biosystems Limited (ASX: IBX) today announces positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility of MagSense® HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for…
Posted: 12 December 2023 Victoria’s standing as a leading producer of life-saving vaccines and medicines will grow with global giant BioNTech creating a research and manufacturing facility in Melbourne, in partnership with the Allan Labor Government. Building on…
Posted: 12 December 2023 In a significant breakthrough published in the top scientific journal, Nature Hudson Institute researchers have linked ovarian cancer to the absence of a naturally occurring protein in the female reproductive tract called interferon epsilon (IFN-e). The…
Posted: 11 December 2023 A Peter Mac-led study has found sharing follow-up care between a GP and hospital-based specialists was preferred by bowel cancer patients, was cheaper for the healthcare system and was just as effective as standard…
Posted: 11 December 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce it has received a €1,595,475 (~…
Posted: 11 December 2023 Telix announces positive topline results from the Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candidate, TLX250-CDx (89Zr-DFO-girentuximab), in patients with triple negative breast cancer…
Posted: 11 December 2023 I am very proud to announce the results of our BANDIT trial – a world-first clinical trial investigating the use of an existing immunotherapy drug (baricitinib) to slow or stop the killing of insulin-producing…